Strength
25 mg/1
Manufacturer
Padagis Israel Pharmaceuticals LtdNDC
45802015065
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
4/22/2026
Active Ingredients
ALOGLIPTIN BENZOATEApproval Type
Authorized Generic (NDA)
FDA Application
NDA022271On Market Since
4/8/2016
Pharmacological Classes
Dipeptidyl Peptidase 4 Inhibitor
Dipeptidyl Peptidase 4 Inhibitors
Generic Alternatives
No alternatives available
No alternatives found with the same active ingredient, strength, and dosage form.
Related Drugs
Same classification
SAXAGLIPTIN HCL 5 MG TABLET
Generic
00378470677•Mylan Pharmaceuticals Inc.
$1.1692
per EA
SAXAGLIPTIN HCL 5 MG TABLET
Generic
00378470693•Mylan Pharmaceuticals Inc.
$1.1692
per EA
SAXAGLIPTIN HCL 5 MG TABLET
Generic
65862082630•Aurobindo Pharma Limited
$1.1692
per EA
SAXAGLIPTIN HCL 5 MG TABLET
Generic
65862082690•Aurobindo Pharma Limited
$1.1692
per EA
SAXAGLIPTIN HCL 5 MG TABLET
Generic
68462072730•Glenmark Pharmaceuticals Inc., USA
$1.1692
per EA
SAXAGLIPTIN HCL 5 MG TABLET
Generic
68462072790•Glenmark Pharmaceuticals Inc., USA
$1.1692
per EA
SAXAGLIPTIN HCL 2.5 MG TABLET
Generic
00378470577•Mylan Pharmaceuticals Inc.
$1.2833
per EA
SAXAGLIPTIN HCL 2.5 MG TABLET
Generic
00378470593•Mylan Pharmaceuticals Inc.
$1.2833
per EA
SAXAGLIPTIN HCL 2.5 MG TABLET
Generic
65862082530•Aurobindo Pharma Limited
$1.2833
per EA
SAXAGLIPTIN HCL 2.5 MG TABLET
Generic
65862082590•Aurobindo Pharma Limited
$1.2833
per EA